News

The PAM Health Rehabilitation of Tulsa held free mini screenings to show stroke survivors a new FDA-approved rehabilitation ...
After flexing its antibody-drug conjugate bona fides at last year’s American Society of Clinical Oncology (ASCO) conference, ...
FDA grants accelerated approval to AbbVie's Emrelis for c-Met overexpressing NSCLC; siRNA partnership with ADARx includes ...
The U.S. Food and Drug Administration has approved AbbVie's drug to treat adults with a type of lung cancer who have received ...
Merck (MRK) stock in focus as the FDA approves its anticancer agent Welireg for two rare neuroendocrine tumors, expanding its ...
Orchestra BioMed's AVIM earns FDA breakthrough designation, sparking investor optimism. Click here to read why OBIO stock is ...
Red dye No. 3 is now banned in the US -- but it'll take time to phase it out completely. In the meantime, the FDA just ...
FDA will implement a secure generative AI system across all centers by June 30, aiming to streamline internal reviews and ...
The U.S. Food and Drug Administration has approved Verastem's combination therapy for patients with a rare type of ovarian ...
The Trump administration argues that Kansas, Idaho, and Missouri have no standing sue the FDA over abortion pills in the Northern District of Texas.
Novo Nordisk's collaboration with telehealth providers offers semaglutide at $499/month, enhancing access for self-paying ...
The Nasdaq exchange filed a 19b-4 form with the Securities and Exchange Commission (SEC) on Tuesday to approve listing and trading shares of the 21Shares Dogecoin ETF. Asset manager 21Shares ...